← Insider buys
CRNX

Crinetics Pharmaceuticals, Inc. · Healthcare

CFO Marc Wilson sold $298K of Crinetics Pharmaceuticals, Inc.

Sold$297,881
$42.91Price
6,942Shares
−6%Stake

What CRNX did after the filing

Filed Mar 20, copier in the same day
The stock from Wed, Mar 20 close, $45.49
+2.8%
S&P 500, same days
−3.0%

Measured over 30 trading days, to the May 2 close.

Traded Tue, Mar 19. Filed Wed, Mar 20, 2:32 PM ET, during the session. Returns use the Mar 20 close and the May 2 close. Not investment advice.